Andrew T. Turk

1.1k total citations
39 papers, 650 citations indexed

About

Andrew T. Turk is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrew T. Turk has authored 39 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Oncology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrew T. Turk's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Thyroid and Parathyroid Surgery (6 papers). Andrew T. Turk is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Thyroid and Parathyroid Surgery (6 papers). Andrew T. Turk collaborates with scholars based in United States, Italy and Canada. Andrew T. Turk's co-authors include Bruce M. Wenig, Ketan K. Badani, Gregory W. Hruby, Mark L. Urken, Guo‐Xia Tong, Jason B. Clain, Gloria H. Su, Saral Mehra, Matthew D. Truesdale and Philippa Cheetham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Andrew T. Turk

38 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew T. Turk United States 15 275 244 168 160 153 39 650
Shipra Agarwal India 13 207 0.8× 208 0.9× 199 1.2× 107 0.7× 99 0.6× 83 616
Juliette Haudebourg France 14 208 0.8× 112 0.5× 206 1.2× 144 0.9× 268 1.8× 37 651
Michael S. Landau United States 17 218 0.8× 212 0.9× 220 1.3× 96 0.6× 99 0.6× 22 691
Francesca Torresan Italy 14 273 1.0× 356 1.5× 94 0.6× 82 0.5× 52 0.3× 50 578
Ilkka Heiskanen Finland 14 225 0.8× 172 0.7× 217 1.3× 53 0.3× 153 1.0× 31 671
Barbara Gazić Slovenia 13 130 0.5× 193 0.8× 140 0.8× 85 0.5× 80 0.5× 45 506
Mauro Papotti Italy 15 287 1.0× 262 1.1× 367 2.2× 142 0.9× 196 1.3× 24 937
Trisha M. Shattuck United States 8 173 0.6× 249 1.0× 377 2.2× 163 1.0× 133 0.9× 13 902
Tricia A. Moo‐Young United States 15 277 1.0× 326 1.3× 227 1.4× 79 0.5× 49 0.3× 34 687
Stanley Sidhu Australia 15 461 1.7× 521 2.1× 118 0.7× 170 1.1× 98 0.6× 34 902

Countries citing papers authored by Andrew T. Turk

Since Specialization
Citations

This map shows the geographic impact of Andrew T. Turk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Turk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Turk more than expected).

Fields of papers citing papers by Andrew T. Turk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Turk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Turk. The network helps show where Andrew T. Turk may publish in the future.

Co-authorship network of co-authors of Andrew T. Turk

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Turk. A scholar is included among the top collaborators of Andrew T. Turk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Turk. Andrew T. Turk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turk, Andrew T., Darío García‐Carracedo, David T. Kent, et al.. (2020). Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma. Genes & Diseases. 9(3). 820–825. 1 indexed citations
2.
Turk, Andrew T., et al.. (2019). Case report of metastatic prostate cancer to testicles: An ominous sign of advanced disease. Urology Case Reports. 26. 100935–100935. 3 indexed citations
4.
Turk, Andrew T. & Bruce M. Wenig. (2018). Thyroid tumors with follicular architecture. Annals of Diagnostic Pathology. 38. 51–58. 4 indexed citations
6.
Marks, Lianna J., Jennifer A. Oberg, Danielle Pendrick, et al.. (2017). Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Frontiers in Pediatrics. 5. 265–265. 21 indexed citations
7.
Vij, Sarah C., Andrew T. Turk, Tianming Gao, & Daniel A. Shoskes. (2017). Correlation of self-reported urologic symptoms with systemic health conditions in minority men. Translational Andrology and Urology. 6(5). 883–887. 2 indexed citations
8.
Turk, Andrew T., et al.. (2017). Jacobson's Nerve Schwannoma Presenting as a Middle Ear Mass Causing Pulsatile Tinnitus: A Case Report. Otology & Neurotology. 38(9). e354–e356. 1 indexed citations
9.
Sireci, Anthony, Vimla S. Aggarwal, Andrew T. Turk, et al.. (2016). Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center. Journal of Molecular Diagnostics. 19(2). 277–287. 21 indexed citations
10.
Cruz, Filemon S. Dela, Daniel Diolaiti, Andrew T. Turk, et al.. (2016). A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Medicine. 8(1). 116–116. 14 indexed citations
11.
Su, Henry K., Bruce M. Wenig, L. Sylvia, et al.. (2016). Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma. Thyroid. 26(4). 512–517. 53 indexed citations
12.
Whalen, Michael J., Edan Shapiro, Michael B. Rothberg, et al.. (2015). Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins. Urologic Oncology Seminars and Original Investigations. 33(11). 494.e9–494.e14. 7 indexed citations
13.
Qiu, Wanglong, Andrew T. Turk, Anthony Sireci, et al.. (2015). Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Gastroenterology. 150(1). 218–228.e12. 33 indexed citations
14.
Turk, Andrew T.. (2015). Epithelial-Myoepithelial Carcinoma of Salivary Glands. Pathology Case Reviews. 20(1). 17–21.
16.
Clain, Jason B., et al.. (2014). Intrathyroidal Tumors Presenting with Extranodal Extension: What Are We Missing?. Endocrine Pathology. 25(4). 385–389. 2 indexed citations
17.
Turk, Andrew T., Matthias Szabolcs, & Jay H. Lefkowitch. (2013). Portal Hypertension, Nodular Regenerative Hyperplasia of the Liver, and Obstructive Portal Venopathy due to Metastatic Breast Cancer. SHILAP Revista de lepidopterología. 2013. 1–4. 1 indexed citations
18.
Hruby, Gregory W., et al.. (2012). Pathological confirmation of nerve‐sparing types performed during robot‐assisted radical prostatectomy ( RARP ). British Journal of Urology. 111(3). 451–458. 6 indexed citations
19.
Turk, Andrew T., et al.. (2012). Mixed Corticomedullary Carcinoma of the Adrenal Gland: A Case Report. Endocrine Practice. 18(3). e37–e42. 13 indexed citations
20.
Tong, Guo‐Xia, Kalpana Devaraj, Diane Hamele‐Bena, et al.. (2010). Pax8: A marker for carcinoma of Müllerian origin in serous effusions. Diagnostic Cytopathology. 39(8). 562–566. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026